FourThought Financial Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$486K Sell
17,309
-2,468
-12% -$65.7K 0.04% 188
2025
Q4
$492K Sell
19,777
-1,688
-8% -$42.6K 0.04% 213
2025
Q3
$547K Sell
21,465
-6,431
-23% -$159K 0.05% 183
2025
Q2
$676K Sell
27,896
-3,618
-11% -$84.4K 0.07% 161
2025
Q1
$799K Sell
31,514
-178
-0.6% -$4.66K 0.08% 147
2024
Q4
$841K Buy
+31,692
New +$860K 0.09% 146
2024
Q2
Sell
-32,238
Closed -$895K 287
2024
Q1
$895K Sell
32,238
-686
-2% -$19K 0.1% 143
2023
Q4
$948K Buy
32,924
+146
+0.4% +$4.41K 0.12% 132
2023
Q3
$1.09M Buy
32,778
+2,739
+9% +$96.9K 0.15% 106
2023
Q2
$1.1M Sell
30,039
-1,749
-6% -$68.1K 0.14% 112
2023
Q1
$1.3M Buy
31,788
+1,257
+4% +$54.3K 0.18% 106
2022
Q4
$1.56M Buy
+30,531
New +$1.46M 0.23% 94

Other funds holding PFE

FourThought Financial Partners's PFE Position: Q1 2026 in Review

FourThought Financial Partners reduced its Pfizer (PFE) stake by 12% in Q1 2026, selling an estimated $65.7K and leaving 17,309 shares worth $486K. The position accounts for 0.04% of the portfolio, ranked #188.

FourThought Financial Partners first reported a position in PFE in Q4 2022 and has held it in 12 quarters since. The position peaked at $1.56M in Q4 2022. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • FourThought Financial Partners held 17,309 shares of Pfizer worth $486K as of Q1 2026.
  • FourThought Financial Partners sold 2,468 Pfizer shares in Q1 2026, an estimated $65.7K.
  • Pfizer made up 0.04% of FourThought Financial Partners's portfolio in Q1 2026, its #188 holding.
  • FourThought Financial Partners first reported a position in Pfizer in Q4 2022 and has held it in 12 quarters since.
  • FourThought Financial Partners's Pfizer position peaked at $1.56M in Q4 2022.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on FourThought Financial Partners's 13F filing for Q1 2026, filed 7 May 2026.